GSK ties up with gene editing start-up Mammoth for COVID-19 test
By Manas Mishra (Reuters) - GlaxoSmithKline's consumer health unit has tied up with Mammoth Biosciences to develop a test that uses a technology commonly used in gene editing to detect novel coronavirus infections, the California-based startup said on Wednesday. The CRISPR gene editing platform has been hailed as a scientific breakthrough that could lead to cures for diseases driven by genetic mutations or abnormalities, but it has not yielded any approved treatments to date
COVID-19 test" src="https://images.firstpost.com/wp-content/uploads/reuters/05-2020/21/2020-05-20T164134Z_1_LYNXMPEG4J1KL_RTROPTP_2_GSK-RESULTS.jpg" alt="GSK ties up with gene editing startup Mammoth for COVID19 test" width="300" height="225" />
By Manas Mishra
(Reuters) - GlaxoSmithKline's consumer health unit has tied up with Mammoth Biosciences to develop a test that uses a technology commonly used in gene editing to detect novel coronavirus infections, the California-based startup said on Wednesday.
The CRISPR gene editing platform has been hailed as a scientific breakthrough that could lead to cures for diseases driven by genetic mutations or abnormalities, but it has not yielded any approved treatments to date.
The companies aim to develop a new rapid test that can be used by a consumer at home, although Mammoth said it expects the test to initially be used in a clinical setting.
The test will use Mammoth's CRISPR-based platform to identify the presence of viral RNA strands through a nasal swab and deliver results in less than 20 minutes, Mammoth said.
Healthcare professionals have stressed that the accuracy of a nasal swab test depends on how well the sample is taken - posing a challenge for household use without professional assistance.
Mammoth, co-founded by early gene editing pioneer Jennifer Doudna, was the first to develop a CRISPR platform as a disease detection system.
The tie-up marks a push into coronavirus diagnostics for Britain-based GlaxoSmithKline. Pfizer Inc holds a more than 30% stake in GSK Consumer Healthcare.
Earlier this year, GSK had partnered with Sanofi SA to develop a vaccine against the coronavirus that has killed over 322,000 worldwide.
"Using this CRISPR-based technology, you can actually create accurate tests, giving similar quality to what's in the lab but in a 'de-centralized' format," said Trevor Martin, Mammoth's chief executive officer.
GSK and Mammoth expect to submit an application to gain the U.S. Food and Drug Administration's emergency use authorization by the end of the year.
(Reporting by Manas Mishra in Bengaluru; Editing by Amy Caren Daniel)
This story has not been edited by Firstpost staff and is generated by auto-feed.
By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States
BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.